Clover Health Investments (CLOV) Gross Profit (2020 - 2026)

Clover Health Investments has reported Gross Profit for 7 years, with the latest figure at $154.5 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit rose 41.93% year-over-year to $154.5 million; the trailing twelve-month figure through Mar 2026 stood at $399.7 million (up 1.99% YoY), and the FY2025 full-year result was $323.3 million, down 11.37% from the prior year.
• Gross Profit for Q1 2026 stood at $154.5 million, up from $72.4 million in the prior quarter.
• The five-year high for Gross Profit was $154.5 million in Q1 2026, with the low at -$590.3 million in Q2 2022.
• Historically, Gross Profit has averaged $1.8 million across 5 years, with a median of $73.2 million in 2025.
• Annual changes were most pronounced in 2022 — Gross Profit sank 3778.98% — and 2023, when it jumped 312.76%.
• Clover Health Investments' Gross Profit stood at $74.2 million in 2022, then retreated by 15.6% to $62.6 million in 2023, then surged by 49.96% to $93.9 million in 2024, then retreated by 22.94% to $72.4 million in 2025, then jumped by 113.53% to $154.5 million in 2026.
• The last three Gross Profit figures came in at $154.5 million (Q1 2026), $72.4 million (Q4 2025), and $73.2 million (Q3 2025), per Business Quant data.